Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutogliptin in type 2 diabetes mellitus on pioglitazone
NCT00970424Phase 3Terminated
- Sponsor
- Forest Laboratories
- Start
- Aug 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of dutogliptin in type 2 diabetes mellitus (T2DM), sponsored by Forest Laboratories. Started Aug 2009; status: terminated.
02
Drugs
dutogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00970424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00970424.